184 related articles for article (PubMed ID: 17625308)
21. Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?
Hellmig S; Fölsch UR
Dig Liver Dis; 2006 Aug; 38(8):596-8. PubMed ID: 16731061
[No Abstract] [Full Text] [Related]
22. Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography.
Guglielmi V; Tutino M; Guerra V; Giorgio P
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5268-5274. PubMed ID: 29228444
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
Chiu YJ; Chen SC; Kang YN; Hou SK; Chao CC; Chang CC
J Formos Med Assoc; 2021 Apr; 120(4):1090-1099. PubMed ID: 33183879
[TBL] [Abstract][Full Text] [Related]
24. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
Masci E; Cavallini G; Mariani A; Frulloni L; Testoni PA; Curioni S; Tittobello A; Uomo G; Costamagna G; Zambelli S; Macarri G; Innocenti P; Dragonetti C;
Am J Gastroenterol; 2003 Oct; 98(10):2182-6. PubMed ID: 14572565
[TBL] [Abstract][Full Text] [Related]
26. Risk for post-ERCP pancreatitis after needle knife precut sphincterotomy following repeated cannulation attempts.
Lee JK; Park JK; Yoon WJ; Lee SH; Lee KH; Ryu JK; Kim YT; Yoon YB
J Clin Gastroenterol; 2007 Apr; 41(4):427-31. PubMed ID: 17413615
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pande H; Thuluvath P
Drugs; 2003; 63(17):1799-812. PubMed ID: 12921486
[TBL] [Abstract][Full Text] [Related]
28. Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis.
Wang G; Liu Y; Zhou SF; Qiu P; Xu L; Wen P; Wen J; Xiao X
Am J Med Sci; 2016 May; 351(5):506-12. PubMed ID: 27140710
[TBL] [Abstract][Full Text] [Related]
29. Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?
Ziebert JJ; Bjorkman DJ
Am J Gastroenterol; 1997 Jun; 92(6):1067-8. PubMed ID: 9177543
[No Abstract] [Full Text] [Related]
30. Pharmacological management of pancreatitis.
Hoogerwerf WA
Curr Opin Pharmacol; 2005 Dec; 5(6):578-82. PubMed ID: 16198632
[TBL] [Abstract][Full Text] [Related]
31. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
32. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
[TBL] [Abstract][Full Text] [Related]
33. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
[TBL] [Abstract][Full Text] [Related]
34. [Can post-ERCP acute pancreatitis be predicted and prevented?].
Heyries L
Gastroenterol Clin Biol; 2001 Jan; 25(1 Suppl):1S241-6. PubMed ID: 11223596
[No Abstract] [Full Text] [Related]
35. Prevention of ERCP-induced pancreatitis: success at last.
Pasricha P
Gastroenterology; 1997 Apr; 112(4):1415-7. PubMed ID: 9098032
[No Abstract] [Full Text] [Related]
36. Prevention of post-ERCP pancreatitis.
Haber GB
Gastrointest Endosc; 2000 Jan; 51(1):100-3. PubMed ID: 10625814
[No Abstract] [Full Text] [Related]
37. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography.
Schneider J; Barkin J
Gastrointest Endosc; 1997 May; 45(5):447-8. PubMed ID: 9165340
[No Abstract] [Full Text] [Related]
38. Predicting and preventing post-ERCP pancreatitis.
Baillie J
Curr Gastroenterol Rep; 2002 Apr; 4(2):112-9. PubMed ID: 11900675
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.
Yuhara H; Ogawa M; Kawaguchi Y; Igarashi M; Shimosegawa T; Mine T
J Gastroenterol; 2014 Mar; 49(3):388-99. PubMed ID: 23720090
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin bolus injection for post-ERCP pancreatitis prevention: a need for further study.
Rudin D
Gastrointest Endosc; 2008 Jan; 67(1):190; author reply 190-1. PubMed ID: 18155442
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
